Skip to main content
. 2021 Apr 22;106(10):2654–2666. doi: 10.3324/haematol.2021.278427

Figure 4.

Figure 4.

Schematic overview of identified malignant rearrangements in cohorts 2 and 3 with nodular lymphocyte-predominant Hodgkin lymphoma. NLPHL: nodular lymphocyte-predominant Hodgkin lymphoma; DLBCL: diffuse large B-cell lymphoma; ID: initial diagnosis; Rel: relapse; Trafo: transformation; LP: lymphocyte predominant.